1. Academic Validation
  2. Efficacy of cefiderocol in combination with xeruborbactam versus taniborbactam against cefiderocol-resistant NDM-producing Pseudomonas aeruginosa

Efficacy of cefiderocol in combination with xeruborbactam versus taniborbactam against cefiderocol-resistant NDM-producing Pseudomonas aeruginosa

  • Antimicrob Agents Chemother. 2025 Oct 10:e0085725. doi: 10.1128/aac.00857-25.
Kaan Kocer 1 2 Truong Nhat My 3 4 Bui Tien Sy 3 4 Lisa Göpel 1 Thirumalaisamy P Velavan 3 5 6 7 Le Huu Song 3 4 6 Silke Peter 7 8 Sébastien Boutin 1 2 9 Adesola Olalekan 10 Dennis Nurjadi 1 2 3
Affiliations

Affiliations

  • 1 Institute of Medical Microbiology, University of Lübeck and University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany.
  • 2 German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Lübeck, Germany.
  • 3 Vietnamese-German Centre for Medical Research (VG-CARE), Hanoi, Vietnam.
  • 4 108 Military Central Hospital, Hanoi, Vietnam.
  • 5 Faculty of Medicine, Duy Tan University, Da Nang, Vietnam.
  • 6 Institute of Tropical Medicine, Universitätsklinikum Tübingen, Tübingen, Germany.
  • 7 German Center for Infection Research (DZIF), Partner Site Tübingen, Tübingen, Germany.
  • 8 Institute of Medical Microbiology and Hygiene, Universitätsklinikum Tübingen, Tübingen, Germany.
  • 9 Airway Research Center North (ARCN), German Center for Lung Research (DZL), Lübeck, Germany.
  • 10 Department of Medical Laboratory Science, College of Medicine, University of Lagos, Lagos, Nigeria.
Abstract

We evaluated the in vitro activity of cefiderocol in combination with either taniborbactam or xeruborbactam against cefiderocol-resistant, blaNDM-positive Pseudomonas aeruginosa clinical isolates from Vietnam and Nigeria. Taniborbactam restored cefiderocol susceptibility in most isolates (20/21, 95.2%), while xeruborbactam had no effect. Resistance was reversed by dipicolinic acid, which confirmed New-Delhi Metallo-β-lactamase (NDM-mediated) resistance. One isolate that was unresponsive to taniborbactam carried multiple copies of blaNDM-1. These findings highlight the species-specific limitations of xeruborbactam in P. aeruginosa.

Keywords

NDM; Pseudomonas aeruginosa; cefiderocol; taniborbactam; xeruborbactam.

Figures
Products